Tryggeseth A
Tidsskr Nor Laegeforen. 1990 Aug 20;110(19):2539-40.
In 98 type 2-diabetics with stable fasting blood glucose who were treated by tablets and/or diet, fasting blood glucose, glycosylated hemoglobin A1c and serum fructosamine were measured simultaneously. Fasting blood glucose was defined as stable when all values were less than 7.1 mmol/l, or deviated by less than 20% in at least three months, and the treatment had not been changed during the last six months. There is satisfactory correlation between fasting blood glucose and glycosylated hemoglobin A1c (r = 0.64), and serum fructosamine (r = 0.63). It is concluded that glycosylated hemoglobin and fructosamine are superfluous in routine controls of such patients. When fasting blood glucose is unsuitable for practical reasons, fructosamine is a good and cheap alternative. In annual controls glycosylated hemoglobin is the best parameter, and reflects the longest period of metabolic control.
对98例通过口服降糖药和/或饮食治疗且空腹血糖稳定的2型糖尿病患者,同时测定空腹血糖、糖化血红蛋白A1c和血清果糖胺。当所有值均低于7.1 mmol/l,或至少三个月内偏差小于20%,且在过去六个月内治疗未改变时,空腹血糖被定义为稳定。空腹血糖与糖化血红蛋白A1c(r = 0.64)以及血清果糖胺(r = 0.63)之间存在良好相关性。结论是,对于此类患者的常规监测,糖化血红蛋白和果糖胺是多余的。当因实际原因空腹血糖不适用时,果糖胺是一种良好且廉价的替代指标。在年度监测中,糖化血红蛋白是最佳参数,且反映代谢控制的最长时间段。